DMK Pharma Sues Drug Co. It Claims Helped Drive It To Ch. 11

By Clara Geoghegan · June 4, 2024, 6:20 PM EDT

Drug developer DMK Pharmaceuticals has asked a Delaware bankruptcy judge to award it $328.7 million from pharmaceutical company US WorldMeds LLC, saying USWM didn't properly market an opioid-overdose intervention product, resulting...

To view the full article, register now.

Bankruptcy Scorecard


DMK Pharmaceuticals has applied for Chapter 11 protection in Delaware, citing recent clinical trial failures and product recalls, as well as the government's allegation that a subsidiary engaged in criminal activities, as reasons for seeking bankruptcy relief.

Case Number



Mary F. Walrath


U.S. Bankruptcy Court for the District of Delaware

Capital Structure

Total Liabilities:


View Full Scorecard